Filana Therapeutics, Inc. Common Stock (FLNA) Stock
NYSE · FLNA
0.73
Fundamentals
Market cap
$35.07M
Price / Earnings ratio
-0.8x
Price / Sales ratio
N/A
Price / Book ratio
0.6x
Return on assets
-0.6%
Ex-Dividend date
13 Dec 2012
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A
Latest news
About Filana Therapeutics, Inc. Common Stock
No description available.
SectorHealthcare
IndustryBiotechnology
Employees17
CEOMr. Richard Jon Barry
IPO DateJul 14, 2000
HeadquartersAustin, TX
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. Richard Jon Barry | CEO, President & Director | 1959 |
| Mr. Eric J. Schoen | Chief Financial Officer | 1968 |
| Mr. R. Christopher Cook J.D. | Chief Operating & Legal Officer | 1964 |
| Dr. George Thornton Ph.D. | Senior Vice President of Technology | — |
| Mr. Michael Zamloot | Senior Vice President of Technical Operations | — |
| Jaren Landen | Chief Clinical Development Officer | — |
| Dr. Angelique Bordey Ph.D. | Senior Vice President of Neuroscience | — |
| Mr. Jack Moore Ph.D. | Senior Vice President of Clinical Development | — |
| Dr. Joseph Hulihan M.D. | Chief Medical Officer | 1956 |
| Ms. Nancy Teasdale | Head of Regulatory Affairs | — |
Fundamentals
Valuation
Market cap$35.07M
Price-to-sales ratioN/A
Price-to-book value0.55
Price-earnings ratio-0.80
Return on Equity-100.00%
Return on SalesN/A
Return on AssetsN/A
PEG ratio1.62
Earnings Per Share
Earnings Per Share$-0.87
Income Statement
Average volume270,674
EBITDA$-76.94M
1 year high (52w)$2.27
1 year low (52w)$0.67
Dividend
Ex dividend date13 Dec 2012
Dividend amount$0.00
Dividend yield0.00%
Last payment dateN/A
Dividend yield (TTM)N/A
Next earnings reportN/A
Solvency
Debt-to-equity ratioN/A



